Seminars in Oncology
Volume 34, Issue 2 , Pages 122-128 , April 2007

Perioperative Chemotherapy in Muscle-Invasive Bladder Cancer to Enhance Survival and/or as a Strategy for Bladder Preservation

  • Cora N. Sternberg

      Affiliations

    • Corresponding Author InformationAddress correspondence to Cora N. Sternberg, MD, FACP, Chairman, Department of Medical Oncology, San Camillo and Forlanini Hospitals, Nuovi Padiglioni, 4th Floor, Circonvallazione Gianicolense 87, Rome, Italy 00152.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  2. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: A contemporary series. J Urol. 2001;165:1111–1116
  3. Bassi P, Ferrante GD, Piazza N, et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort. J Urol. 1999;161:1494–1497
  4. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675
  5. Sternberg CN, Yagoda A, Scher HI, et al. Preliminary results of methotrexate, vinblastine, Adriamycin and cisplatin (M-VAC) in advanced urothelial tumors. J Urol. 1985;133:403–407
  6. Sternberg CN. Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer. In:  Lerner SP,  Schoenberg MP,  Sternberg CN editor. Textbook of Bladder Cancer. Abingdon, UK: Taylor & Francis; 2006;p. 657–664
  7. Sternberg CN. Current perspectives in muscle invasive bladder cancer. Eur J Cancer. 2002;38:460–467
  8. Sternberg CN, Pansadoro V, Calabro F, et al. Can patient selection for bladder preservation be based on response to chemotherapy?. Cancer. 2003;97:1644–1652
  9. Herr HW, Scher HI. Surgery of invasive bladder cancer: Is pathologic staging necessary?. Semin Oncol. 1990;17:590–597
  10. Frazier HA, Robertson JE, Dodge RK, et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1993;71:3993–4001
  11. Amling CL, Thrasher JB, Frazier HA, et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol. 1994;15:31–35
  12. Stein JP. Indications for early cystectomy. Semin Urol Oncol. 2000;18:289–295
  13. Sanchez-Ortiz RF, Huang WC, Mick R, et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003;169:110–115
  14. Stein JP. Contemporary concepts of radical cystectomy and the treatment of bladder cancer. J Urol. 2003;169:116–117
  15. Millikan R, Dinney C, Swanson D, et al. Integrated therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol. 2001;19:4005–4013
  16. Hall MC, Swanson DA, Dinney CP. Complications of radical cystectomy: Impact of the timing of perioperative chemotherapy. Urology. 1996;47:826–830
  17. Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349:859–866
  18. Grossman HB, Natale RB, Tangen CM, et al. Errata Corrige for: “Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer” published in N Engl J Med. 2003 Aug 28;349(9):859-66 N Engl J Med. 2003;349:1880
  19. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: A randomised controlled trial. Lancet. 1999;354:533–540
  20. Hall RR International Collaboration of Trialists of the MRC Advanced Bladder Cancer Group. Updated results of a randomised controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. J Clin Oncol. 2002;21:178a;(abstr 710)
  21. Bassi P, Pagano F, Pappagallo G, et al. Neoadjuvant M-VAC of invasive bladder cancer: The G.U.O.N.E. multicenter phase III trial. Eur Urol. 1998;33:142;(suppl 1, abstr)
  22. Malmstrom PU, Rintala E, Wahlqvist R, et al. Five year follow-up of a prospective trial of radical cystectomy and neoadjuvant chemotherapy. J Urol. 1996;155:1903–1906
  23. Sherif A, Rintala E, Mestad O, et al. Neoadjuvant cisplatin-methotrexate chemotherapy of invasive bladder cancer—Nordic cystectomy trial 2. Scand J Urol Nephrol. 2002;36:419–425
  24. Wallace DM, Raghavan D, Kelly KA, et al. Neoadjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol. 1991;67:608–615
  25. Coppin CM, Gospodarowicz MK, James K, et al. The National Cancer Institute of Canada Clinical Trials Group Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol. 1996;14:2901–2907
  26. Martinez Pineiro JA, Gonzalez Martin M, Arocena F. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: Prospective randomized phase III study. J Urol. 1995;153:964–973
  27. Natale RB, Grossman HB, Blumenstein B, et al. SWOG 8710 (INT-0080): Randomized phase III trial of neoadjuvant M-VAC and cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. Proc Am Soc Clin Oncol. 2001;20:2a;(abstr)
  28. GISTV (Italian Bladder Cancer Study Group). Neoadjuvant treatment for locally advanced bladder cancer: A randomized prospective clinical trial. J Chemother. 1996;8:345–346
  29. Orsatti M, Curotto A, Canobbio L. Alternating chemo-radiotherapy in bladder cancer: A conservative approach. Int J Radiat Oncol Biol Phys. 1995;33:173–178
  30. Abol-Enein H, El Makresh M, El Baz M, et al. Neoadjuvant chemotherapy in treatment of invasive transitional bladder cancer: A controlled, prospective randomised study. Br J Urol. 1997;80(suppl 2):49
  31. Sylvester RJ, Yamaguchi T. Clinical trial design. In:  Lerner SP,  Schoenberg MP,  Sternberg CN editor. Textbook of Bladder Cancer. Abingdon, UK: Taylor & Francis; 2006;p. 647–655
  32. Sternberg CN, Parmar MKB. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle invasive bladder cancer. J Clin Oncol. 2001;19(suppl 1):21S–26S
  33. Winquist E, Kirchner TS, Segal R, et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysis (Genitourinary Cancer Disease Site Group, Cancer Care Ontario Program in Evidence-based Care Practice Guidelines Initiative). J Urol. 2004;171:561–569
  34. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;48:202–205
  35. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol. 2005;48:189–199
  36. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet. 2003;361:1927–1934
  37. Sherif A, Holmberg L, Rintala E, et al. Nordic Urothelial Cancer Group Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: A combined analysis of two Nordic studies. Eur Urol. 2004;45:297–303
  38. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: A cooperative group report. J Clin Oncol. 2004;22:2781–2789
  39. Droz JP. Editorial comment on “Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration”. Eur Urol. 2005;48:205–206
  40. Solsona E. Radical TURBT. In:  Lerner SP,  Schoenberg MP,  Sternberg CN editor. Textbook of Bladder Cancer. Abingdon, UK: Taylor & Francis; 2006;p. 535–541
  41. Hautmann RE. Urinary diversion: Ileal conduit to neobladder. J Urol. 2003;169:834–842
  42. Herr HW. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol. 2001;19:89–93
  43. Solsona E, Iborra I, Ricos JV, et al. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: Long-term followup of a prospective study. J Urol. 1998;159:95–99
  44. Schultz PK, Herr HW, Zhang Z. Neoadjuvant chemotherapy for invasive bladder cancer: Prognostic factors for survival of patients with M-VAC with 5 years follow-up. J Clin Oncol. 1994;12:1394–1401
  45. Herr HW, Scher HI. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol. 1994;12:975–980
  46. Sternberg CN. Chemotherapy for local treatment of bladder cancer. Semin Radiat Oncol. 2005;15:60–65
  47. Herr HW. Uncertainty and outcome of invasive bladder tumors. Urol Oncol. 1996;2:92–95
  48. Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol. 1998;16:1298–1301
  49. Chang SS, Hassan JM, Cookson MS, et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003;170:1085–1087
  50. Skinner DG, Daniels JR, Russell CA, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol. 1991;145:459–467
  51. Stockle M, Meyenburg W, Wellek S, et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 nad pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy results of a controlled prospective study. J Urol. 1992;148:302–307
  52. Stockle M, Meyenburg W, Wellek S. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: Long term results of a controlled prospective study and further clinical experience. J Urol. 1995;153:47–52
  53. Lehmann J, Franzaring L, Thuroff J, et al. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. Br J Urol Int. 2006;97:42–47
  54. Otto T, Börgemann C, Krege S, et al. Adjuvant chemotherapy in locally advanced bladder cancer (PT3/PN1-2,M0)—A phase III study. Eur Urol. 2001;39:147;(suppl 5, abstr)
  55. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why. Ann Oncol. 2000;11:851–856
  56. Jin JO, Boyar M, Petrylak DP, et al. Adjuvant chemotherapy for invasive bladder cancer. In:  Lerner SP,  Schoenberg MP,  Sternberg CN editor. Textbook of Bladder Cancer. Abingdon, UK: Taylor & Francis; 2006;p. 665–670
  57. Dreicer R, Manola J, Roth BJ, et al. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium. Cancer. 2004;100:1639–1645
  58. Sternberg CN, Cote R. p53 Alterations in bladder cancer. J Eur Urol. 2005;12–13Dec
  59. Logothetis CJ, Johnson DE, Chong C, et al. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: An update. J Clin Oncol. 1988;6:1590–1596
  60. Studer UE, Bacchi M, Biedermann C, et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: Results of a prospective randomized trial. J Urol. 1994;152:81–84
  61. Bono AV, Benvenuti C, Gibba A, et al. Adjuvant chemotherapy in locally advanced bladder cancer (Final analysis of a controlled multicentre study). Acta Urol Ital. 1997;11:5–8
  62. Freiha F, Reese J, Torti FM. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine, and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol. 1996;155:495–499

PII: S0093-7754(06)00483-0

doi: 10.1053/j.seminoncol.2006.12.006

Seminars in Oncology
Volume 34, Issue 2 , Pages 122-128 , April 2007

Article Tools